Loading…
Loading…
HSIC · NASDAQ · Healthcare
“At 21.6 times earnings, HSIC's valuation demands scrutinizing whether the dental supply business justifies such premium pricing against conservative intrinsic value estimates.”
— In the voice of Graham
Project future earnings using analyst estimates and historical growth rates. Model 5-year earnings trajectories.
Market Cap
$8.61B
P/E Ratio
21.63
Forward P/E
—
EPS
$3.29
PEG Ratio
1.62
Book Value
$26.86
Dividend Yield
—
Profit Margin
3.02%
ROE
12.27%
Use the interactive growth projection with pre-loaded data for Henry Schein Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for HSIC: